The assessment of compliance with legal limits. Part 2. How to consider both type I and type II errors when working in the concentration domain

Author： Desimoni E.  

Publisher： Springer Publishing Company

ISSN： 0949-1775

Source： Accreditation and Quality Assurance, Vol.9, Iss.8, 2004-07, pp. : 445-449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ingested Type I Interferon—State of the Art as Treatment for Autoimmunity Part 2

By Brod Staley A.  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1108-1121

MDPI

Access to resources Recommend Favorite

Purification and crystallization of a multimodular heterotrimeric complex containing both type I and type II cohesin–dockerin interactions from the cellulosome of Clostridium thermocellum

By  

Acta Crystallographica Section F, Vol. 66, Iss. 3, 2010-03 ,pp. : 327-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiproliferative Properties of Type I and Type II Interferon

By Bekisz Joseph   Baron Samuel   Balinsky Corey   Morrow Angel   Zoon Kathryn C.  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-03 ,pp. : 994-1015

MDPI

Access to resources Recommend Favorite

The Seasonal Behavior of Type I and Type II Diseases

By  

International Journal of Chemical Modeling, Vol. , Iss. , 2016-01 ,pp. : 136-135

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

A Brief History of the Classification of Type I and Type II Diseases

By  

International Journal of Chemical Modeling, Vol. , Iss. , 2016-01 ,pp. : 117-116

Nova Science Publishers, Inc.

Access to resources Recommend Favorite